Dopamine: A New Player in the Pathogenesis of Diabetic Retinopathy?

Marianthi Ntikoudi, Theofano Myrto Farmaki, Konstantinos Tziomalos · 2024

Read Dopamine: A New Player in the Pathogenesis of Diabetic Retinopathy? by Marianthi Ntikoudi, Theofano Myrto Farmaki, Konstantinos Tziomalos (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642112.txt.

Description

Marianthi Ntikoudi, Theofano Myrto Farmaki, and Konstantinos Tziomalos published this short review in 2024. Diabetic retinopathy is a leading cause of blindness, and many factors behind it are still not fully known. Treatment options are therefore limited. Recent data suggest that dopamine, a messenger better known from the brain, might play a role in how the eye disease grows. The review gathers and weighs that evidence. It also comments on whether changing dopamine signaling could one day help manage this eye complication of diabetes.

Catalog record

CREATORMarianthi Ntikoudi, Theofano Myrto Farmaki, Konstantinos Tziomalos
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11642112

Browse the full library · About the Tower of Babel